Finisar (FNSR) Reports In-Line Q4 EPS, Offers Q1 Gudiance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts FNSR Hot Sheet
Price: $23.77 --0%
Financial Fact:
Basic (in dollars per share): 0.44
Today's EPS Names:
SMXT, NRIX, VFS, More
Financial Fact:
Basic (in dollars per share): 0.44
Today's EPS Names:
SMXT, NRIX, VFS, More
Join SI Premium – FREE
Finisar (NASDAQ: FNSR) reported Q4 EPS of $0.25, in-line with the analyst estimate of $0.25. Revenue for the quarter came in at $320 million versus the consensus estimate of $320.5 million.
Finisar sees Q1 2015 EPS of $0.23-$0.29, versus the consensus of $0.27. Finisar sees Q1 2015 revenue of $308-328 million, versus the consensus of $318.04 million.
For earnings history and earnings-related data on Finisar (FNSR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Cryo-Cell International, Inc. (CCEL) Tops Q3 EPS by 13c
- ImmuCell reports 46% sales increase in Q3 2026
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
